ECU Logo
Department of Internal Medicine
Division of Infectious Diseases

photo of the Brody building


Paul P. Cook, M.D.
Professor of Medicine
Chief, Division of Infectious Diseases
Division of Infectious Diseases

Undergraduate:BS Biochemistry,University of Georgia, Athens, Georgia, 1978
Medical School: M.D., Medical College of Georgia, Augusta, GA 1982

ResidencyNorth Carolina Memorial Hospital, Chapel Hill, NC 1985
Fellowship: Tufts-New England Medical Center, Boston, MA 1988, Infectious Diseases

Areas of Interest:
Antibiotic Management, Clostridium difficile, Tuberculosis

Recent Publications/Abstracts:
  1. Dr. Paul Cook - Gooch M, Rizzo, S.  Reduction in fluoroquinolone use following introduction of ertapenem to hospital formulary associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study. Antimicrob Agents Chemother. 2011;55:5597-5601.
  2. Lewis GJ, Gooch M, Fang X, Cook PP. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital’s intensive and intermediate care units. Infect Control Hosp Epidemiol. 2012;33:368-73.
  3. Dyson OF, Walker LR, Whitehouse A, Cook PP, Akula SM. Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1. PLoSONE. 2012;7(3): e33364. doi:10.1371/journal.pone.0033364.
  4. O’Neal, W, Fang X, Winters M, Augustino K, Cook PP.  TB Screening in an HIV Clinic: How Interferon-γ Assays Improve Screening Compliance. Int J Tuber Lung Dis. 2012;16:707.
  5. Riaawi, R., Kabchi, B., Ashraf, M. S. , Mazer, M., Gooch, M., P Cook, (2012). A REVIEW OF ANTIMICROBIAL USE IN THE MEDICAL ICU - A NEED FOR IMPROVEMENT? 26th Annual Yash P. Kataria Research Day, Greenville, North Carolina.